BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 12402427)

  • 1. [Final results of a randomized clinical trial of adjuvant intraportal chemotherapy for colorectal cancer: Intraportal Chemotherapy for Colorectal Cancer Group].
    Yamamura T; Yabe K; Oka H; Kouzuma T; Kawahara H; Wakayama T; Sugiura A; Hagiwara M; Ohdate K; Miyajima N; Maeda C; Okamura R; Miyahara T; Moriyama Y; Yamaguchi S; Gunji A;
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1765-71. PubMed ID: 12402427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Continuous intraportal chemotherapy for prevention of metachronous hepatic metastasis in colorectal cancer].
    Adachi W; Watanabe H; Yazawa K; Koide N; Koike S; Mihara M; Nakata S; Kajikawa S; Kuroda T; Amano J
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):697-703. PubMed ID: 9571967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
    Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is portal infusion chemotherapy uneffective for hepatic recurrence after resection for colorectal cancer?].
    Yamamura T; Akaishi O; Tsukikawa S; Yamaguchi S; Yabe K
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1756-8. PubMed ID: 10560388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portal vein chemotherapy for colorectal cancer: a meta-analysis of 4000 patients in 10 studies. Liver Infusion Meta-analysis Group.
    J Natl Cancer Inst; 1997 Apr; 89(7):497-505. PubMed ID: 9086006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Status of portal perfusion in colorectal cancer. Swiss Study Group for Clinical Cancer Research].
    Metzger U; Laffer U; Egeli R; Arma S; Aeberhard P; Barras JP; Martinoli S; Müller W; Castiglione M; Schroeder R
    Chirurg; 1994 Jun; 65(6):509-13. PubMed ID: 8088206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized multicenter trial of adjuvant intraportal chemotherapy for colorectal cancer (SAKK 40/81). An interim report.
    Metzger U; Laffer U; Aeberhard P; Arigoni M; Arma S; Barras J; Egeli R; Martinoli S; Mueller W; Schweizer W
    Acta Chir Scand; 1990; 156(6-7):467-74. PubMed ID: 2114722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparing the effect of adjuvant chemotherapy by portal vein infusion with intraluminal chemotherapy for colorectal cancer].
    Pan ZZ; Wan DS; Lu ZH; Li LR; Chen G; Zhou ZW; Wu XJ; Ding PR; Wang FL
    Zhonghua Wai Ke Za Zhi; 2004 Aug; 42(15):918-21. PubMed ID: 15363253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intraportal infusion of 5-FU and lipiodol-aclarubicin after hepatic resection for colorectal liver metastasis].
    Ambiru S; Miyazaki M; Ito H; Kaiho T; Ando K; Hayashi S; Nakajima N
    Nihon Geka Gakkai Zasshi; 1995 Mar; 96(3):145-52. PubMed ID: 7731455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of prophylactic intraportal chemotherapy on liver function, blood profile and survival in patients with colo-rectal cancer].
    Inoue Y; Sawada T; Shimizu T; Ishiguro M; Wakatsuki T; Hamazoe R; Shimizu N; Maeta M; Koga S
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3024-7. PubMed ID: 2506834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Final evaluation of the randomized multicenter study SAKK 40/81: adjuvant portal chemotherapy of curatively resected colorectal cancer].
    Laffer U; Metzger U; Aeberhard P; Arigoni M; Arma S; Barras J; Egeli R; Martinoli S; Müller W; Schweizer W
    Helv Chir Acta; 1992 Mar; 58(5):755-8. PubMed ID: 1592650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Availability of intermittent chemotherapy by reservoir in liver metastasis of colo-rectal cancer].
    Takano S; Fujii M; Teshima Y; Seki N; Yamagata M; Tanaka T; Sakabe T
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2871-4. PubMed ID: 2506825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies.
    Lorenz M; Staib-Sebler E; Gog C; Proschek D; Jauch KW; Ridwelski K; Hohenberger W; Gassel HJ; Lehmann U; Vestweber KH; Padberg W; Zamzow K; Müller HH
    Zentralbl Chir; 2003 Feb; 128(2):87-94. PubMed ID: 12632273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of intraportal chemotherapy in terms of administered dose of 5-FU].
    Yamamura T; Matsuzaki H; Tsukikawa S; Akaishi O; Ozasa T; Miyake H; Tanaka K; Seo K; Oikawa H; Hanai A; Kikuchi K; Yamaguchi S
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1461-3. PubMed ID: 8854780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic artery ligation or embolization and locoregional chemotherapy of liver metastases from colorectal cancer.
    Gerard A; Pector JC; Bleiberg H
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2351-4. PubMed ID: 3137873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant regional chemotherapy after hepatic resection for colorectal metastases.
    Ambiru S; Miyazaki M; Ito H; Nakagawa K; Shimizu H; Nakajima N
    Br J Surg; 1999 Aug; 86(8):1025-31. PubMed ID: 10460638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: A randomized study.
    Tono T; Hasuike Y; Ohzato H; Takatsuka Y; Kikkawa N
    Cancer; 2000 Apr; 88(7):1549-56. PubMed ID: 10738212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Initial results of adjuvant portal liver infusion following radical surgery of colorectal cancer (Swiss Study Group for Epidemiologic and Clinical Cancer Research Study 40/81)].
    Metzger U; Laffer U; Egeli R; Barras J; Martinoli S; Müller W; Arma S; Bär HU; Schweizer W; Aeberhard P
    Helv Chir Acta; 1989 Dec; 56(4):455-60. PubMed ID: 2517282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic recurrence not prevented with low-dosage long-term intraportal 5-FU infusion after resection of colorectal liver metastasis.
    Tsujitani S; Watanabe A; Kakeji Y; Maehara Y; Tomoda H; Furusawa M; Sugimachi K
    Eur J Surg Oncol; 1991 Oct; 17(5):526-9. PubMed ID: 1936301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.